These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4412732)

  • 21. Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer.
    Suciu-Foca N; Buda J; McManus J; Thiem T; Reemtsma K
    Cancer Res; 1973 Oct; 33(10):2373-7. PubMed ID: 4270240
    [No Abstract]   [Full Text] [Related]  

  • 22. Lymphocyte-mediated tumor cell destruction in vitro. Some general principles and reactivities in human urinary bladder carcinoma.
    Perlmann P; O'Toole C; Unsgaard B
    Natl Cancer Inst Monogr; 1972 Dec; 35():223-9. PubMed ID: 4540587
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the induction and expression of T cell-mediated immunity. II. Antiserum blocking of cell-mediated cytolysis.
    Bonavida B
    J Immunol; 1974 Apr; 112(4):1308-21. PubMed ID: 4592598
    [No Abstract]   [Full Text] [Related]  

  • 24. Introduction: interaction of humoral and cellular mechanisms in tumor immunity.
    Hellström KE
    Natl Cancer Inst Monogr; 1972 Dec; 35():221-2. PubMed ID: 4667436
    [No Abstract]   [Full Text] [Related]  

  • 25. Turnover of HL-A antigens at the lymphocyte surface.
    Bernoco D; Mattiuz PL; Miggiano VC; Ceppellini R
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1971; 64(9):272-84. PubMed ID: 4949682
    [No Abstract]   [Full Text] [Related]  

  • 26. Cellular immunity in cancer patients against embryonal cells.
    Fossati G; Canevari S; Della Porta G
    J Natl Cancer Inst; 1973 Aug; 51(2):667-9. PubMed ID: 4765379
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibody-dependent cell-mediated cytotoxicity in prospective kidney transplant recipients.
    Lightbody JJ; Rosenberg JC
    J Immunol; 1974 Mar; 112(3):890-6. PubMed ID: 4590706
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cellular immunity to tumor antigens].
    Hellström KE; Hellström I
    Lakartidningen; 1974 Feb; 71(6):473-8. PubMed ID: 4837237
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of complement in the HL-A antibody-mediated lysis of lymphocytes.
    Ferrone S; Cooper NR; Pellegrino MA; Reisfeld RA
    Transplant Proc; 1974 Mar; 6(1):13-9. PubMed ID: 4856285
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rate of desensitization to HL-A antibodies in phytohaemagglutinin (PHA) stimulated lymphocytes.
    Rugarli C; Scorza R; Sabbadini MG
    Boll Ist Sieroter Milan; 1974; 53(4):573-7. PubMed ID: 4476215
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of spontaneous antibody-dependent cellular cytotoxicity (ADCC) and direct spontaneous lymphocyte-mediated cytotoxicity (SLMC) in patients with neoplasms].
    Degliantoni G; Mangoni L; Manna A; Fulcini M
    G Clin Med; 1981 Sep; 62(9):609-23. PubMed ID: 6976281
    [No Abstract]   [Full Text] [Related]  

  • 33. A lymphocyte cytotoxicity rebound phenomenon induced by enhancing sera.
    Debray-Sachs M; Soucy PE; Hamburger J
    J Immunol; 1973 Mar; 110(3):661-6. PubMed ID: 4569798
    [No Abstract]   [Full Text] [Related]  

  • 34. Biological and chemical aspects of histocompatibility antigens in serum.
    Ferrone S; Pellegrino MA; Allison JP; Reisfeld RA
    Haematologica; 1976 Dec; 61(4):397-417. PubMed ID: 828605
    [No Abstract]   [Full Text] [Related]  

  • 35. Lymphocyte isolation and treatment with AET for routine use in the lymphocytotoxicity test.
    Sirchia G; Scalamogna M; Pizzi C; Mercuriali F
    Tissue Antigens; 1973; 3(2):136-9. PubMed ID: 4771169
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cytotoxic activity of lymphoid cells in cancer].
    Kamenetz LIa; Grinevich IuA
    Vopr Onkol; 1980; 26(7):81-6. PubMed ID: 6996321
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cytotoxic action of lymphocytes].
    Fontana L; Pisarri S; Salsnao F
    Recenti Prog Med; 1973 Sep; 55(3):210-28. PubMed ID: 4801106
    [No Abstract]   [Full Text] [Related]  

  • 38. Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators.
    David JR; David RR
    Prog Allergy; 1972; 16():300-449. PubMed ID: 4564107
    [No Abstract]   [Full Text] [Related]  

  • 39. Lymphocyte-monocyte defect associated with anergy and recurrent infections.
    Louie JS; Goldberg LS
    Clin Exp Immunol; 1972 Jul; 11(3):469-74. PubMed ID: 4625400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies of the behavior of lymphocytes in direct lymphocyte test in surgical patients. II. Dynamics of immune reactivity in selected cases].
    Cybulski L; Turowski G; Zubel M
    Pol Przegl Chir; 1975 Mar; 47(3):337-44. PubMed ID: 1167966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.